✦ LIBER ✦

A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma

✍ Scribed by Qinghua Zhou; Xun Sun; Lingyuan Zeng; Jie Liu; Zhirong Zhang

Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 151 KB
Volume: 5
Category: Article
ISSN: 1549-9634
DOI: 10.1016/j.nano.2009.01.009

No coin nor oath required. For personal study only.

✦ Synopsis

From the clinical editor:

Intravenous administration of mitoxantrone-loaded polybutylcyanacrylate nanoparticles (dhad-pbca-nps) allows increased cytotoxicity in hepatic tumors and prolonged the median survival periods to 5.46 months compared to 3.23 months in controls.

📜 SIMILAR VOLUMES

Thalidomide in the treatment of patients

Thalidomide in the treatment of patients with hepatocellular carcinoma : A Phase II trial

✍ Yehuda Z. Patt; Manal M. Hassan; Richard D. Lozano; Ajay K. Nooka; Isaac I. Schn 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND The treatment of patients with hepatocellular carcinoma (HCC) presents a major challenge, because associated cirrhosis limits the choice of chemotherapeutic agents. However, the abundant vascularity of HCC presents an attractive target for antiangiogenic therapy that pote

A random phase II study of mitoxantrone

A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma: An ECOG study

✍ Geoffrey Falkson; Louise M. Ryan; Lewis A. Johnson; Ian W. Simson; Barend J. Coe 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 3 views

A phase I-II trial of mitoxantrone by he

A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver

✍ Dennie V. Jones Jr.; Yehuda Z. Patt; Jaffer A. Ajani; James Abbruzzese; Bernard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 2 views

A multi-centre randomized phase II study

A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma

✍ Tony S. K. Mok; Thomas W. T. Leung; Shou-Dong Lee; Yee Chao; Anthony T. C. Chan; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 79 KB

Abatacept in the treatment of patients w

Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial

✍ Philip Mease; Mark C. Genovese; Geoffrey Gladstein; Alan J. Kivitz; Christopher 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Mitoxantrone: A phase II study in the tr

Mitoxantrone: A phase II study in the treatment of patients with advanced breast carcinoma and other solid tumours

✍ R. C. Stuart-Harris; I. E. Smith 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 316 KB